Name | JTZ-951 hydrochloride |
---|
Description | A novel potent, orally active HIF prolyl hydroxylase (PHD) inhibitor with IC50 of 0.22 uM for PHD2; increases EPO release from Hep3B cells with EC50 of 5.7 uM, increases hemoglobin levels in rats. Anemia Phase 2 Clinical |
---|---|
References | References 1. Yosuke Ogoshi, et al. ACS Med. Chem. Lett., 2017, 8 (12), pp 1320-1325. View Related Products by Target HIF/HIF Prolyl-hydroxylase Anemia |
Molecular Formula | C17H17ClN4O4 |
---|---|
Molecular Weight | 376.797 |